{'fraction_non_alphanumeric': 0.025974025974025976, 'fraction_numerical': 0.004995004995004995, 'mean_word_length': 5.147239263803681, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prevention of bronchial hyperreactivity in atopic asthmatics during the period of maximal allergenic risk: a six-month study.

Several different parameters of respiratory functions were measured to determine the hyperreactive bronchial responses to the fog-test of 21 atopic asthmatic subjects (prick test and RAST positive for grasses). Measurements were made before and after three and six months of prophylaxis with 1 mg b.i.d. ketotifen, with the period of the trial (April to September) chosen to correspond to the period of maximal allergen exposure. A further 8-patient control group, without prophylactic treatment, underwent the same fog-test and respiratory function measurements were repeated at the same times. In the ketotifen-treated patients almost total protection against the bronchoreactive response to the fog-test was seen after only three months of treatment (in June). The effectiveness of the treatment was maintained to the same extent throughout the rest of the 6-month trial.